Natriuretic fusion proteins

a fusion protein and natriuretic technology, applied in the field of fusion proteins with diuretic, natriuretic, vasodilatory activity, can solve the problems of short half-life of proteins, limited previous therapeutic administration of peptides, and inability to achieve the effect of preventing bacterial infection

Inactive Publication Date: 2010-12-09
BOEHRINGER INGELHEIM INT GMBH +1
View PDF0 Cites 44 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0005]This invention relates to novel, biologically active fusion proteins comprised

Problems solved by technology

Unfortunately, despite this promising clinical application, the therapeutic usefulness of ANP and BNP is sorely limited as endopeptidase degradation, as well as natriuretic peptide clearance receptor (NPR-C) mediated internalization,

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Natriuretic fusion proteins
  • Natriuretic fusion proteins
  • Natriuretic fusion proteins

Examples

Experimental program
Comparison scheme
Effect test

example 1

Structural Modeling to Predict Minimum Linker Distance

[0198]Structural modeling was done to determine the linker requirements for the Fc and ANP fusions. With the both molecules oriented to minimize distance as well as minimize steric and electrostatic repulsions, a minimal distance from the C-terminus of ANP is 12 Å from the closest N-terminus of the Fc dimer and 17 Å from the other N-terminus of the Fc dimer. If the Fc dimer has only one ANP fused, a 4 to 6 aa minimum linker length would be suggested. With two ANP peptides bound to the Fc dimer, if only one ANP bound (in a 1:1 Fc dimer:NPRA ratio) then a minimum linker length of 9 aa for each linker would be suggested. For both ANP's to bind in a 1:2 Fc dimer:NPRA ratio, linkers with a minimum length of 12 aa would be suggested.

example 2

Synthesis and Characterization of Synthetic ANP Fusion Proteins

[0199]Synthetic chemistry was used to generate hANP28 peptides with linkers fused to human Fc of IgG1 isotype. The resulting semi-synthetic ANP-Fc fusion molecules generated are shown in Table 2. The linkers tested were glycine succinate (L1), GlyGly (L2), (GlyGlySer)3GlyGly (L4) (SEQ ID NO: 3) and Gly(SerGlyGly)2SerGly (L3) (SEQ ID NO: 2). The glycines (G) were used to add flexibility, while the polar serines (S) were built in to add solubility. The hANP28 peptides with linkers were linked to recombinantly produced Cys-Fc in two orientations: 1) C-terminus of hANP28+Linker fused to N-terminus of Cys-Fc [Orientation #1], and 2) N-terminus of Linker+hANP28 fused to N-terminus of Cys-Fc [Orientation #2]. The synthetic chemistry of the first orientation resulted in a complete peptide bonded structure while the chemistry of the second orientation left a succinate moiety in place of one amino acid of the fusion.

[0200]The semi...

example 3

Recombinant ANP Fusion Proteins

[0205]A production platform for the rapid generation of recombinant ANP-Fc fusion proteins was generated. The process starts with “base” Fc fusion vectors that allows DNA cassettes to be rapidly and seamlessly inserted onto the N-terminus of either IgG1 or IgG2 Fc. The Fc fusions to both IgG1 and IgG2 isotypes were generated in such a way that the hinge region is chopped down to the same CPPCP hinge residues thus ensuring that the linker extension and ANP fusion would be equally extended on the two isotypes. The respective DNA and protein sequences of the four recombinant ANP-Fc fusion proteins generated are represented by SEQ ID NOs: 24-31 (see, e.g., FIG. 1A-B). These fusion proteins each comprise a N-terminal mouse IgG kappa light chain signal sequence METDTLLLWVPGSTG (SEQ ID NO: 32) that is cleaved off and not part of the final protein product. The bolded The ANP-Fc fusion constructs were initially produced using 1 L transient mammalian expression ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Compositionaaaaaaaaaa
Lengthaaaaaaaaaa
Login to view more

Abstract

Natriuretic peptide fusion proteins comprising natriuretic peptides linked to antibody Fc domains, nucleic acid molecules encoding the fusion proteins disclosed herein, expression vectors expressing said fusion proteins, pharmaceutical compositions comprising said fusion proteins, and methods for their therapeutic use are disclosed.

Description

STATEMENT REGARDING JOINT RESEARCH AGREEMENT[0001]One or more inventions contained in this application were developed under a joint research agreement as defined in the Cooperative Research and Technology Enhancement Act of 2004 between Boehringer Ingelheim International, GmbH and Syntonix Pharmaceuticals, Inc.FIELD OF THE INVENTION[0002]This invention relates to fusion proteins having diuretic, natriuretic, and vasodilatory activity, specifically natriuretic peptides linked to antibody Fc domains. The fusion proteins of this invention exhibit extended plasma half-life compared to wild type natriuretic peptides, which serve as ligands to membrane guanylyl cyclases. The invention is also directed to nucleic acid molecules encoding the fusion proteins disclosed herein, expression vectors expressing said proteins, pharmaceutical compositions comprising the fusion proteins and / or nucleic acid molecules of the present invention. Compositions according to this invention may be administere...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/395C07K16/00C07K14/00C12N15/12C12N15/63C12N5/00C12P21/00A61P9/00A61P31/04A61P11/00A61P13/12
CPCA61K38/00C12N15/62C07K14/58
Inventor CANADA, KEITHSCHOENBECK, UWEHICKEY, EUGENE R.MEZO, ADAMMCDONNELL, KEVIN
Owner BOEHRINGER INGELHEIM INT GMBH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap